In-Depth Study on Global Endometriosis Market 2016-2020

Report : Global Endometriosis Market 2016-2020 is a new market research publication announced by Reportstack.

Report Outline: Endometriosis is a common health condition in women where the endometrial tissue, which is found in the lining of the uterus, appears and grows outside the uterine cavity. The endometrial tissue is shed from the body during menstruation. 

The tissue growing outside the uterine cavity is called endometrial implants. Endometriosis can also occur in the fallopian tubes, ovaries, pelvic cavity, vagina, cervix, and bladder. In rare cases, it has been reported in other parts of the body such as the lungs, brain, and skin. These implants are usually benign in nature. Women of reproductive age are often affected by this condition. 
Endometriosis often occurs due to retrograde menstruation, where the menstrual blood flows back into the pelvic cavity instead of leaving the body. This then adheres to the surface of the bladder, ovaries, or rectum and continues to grow or thicken over the course of each menstrual cycle.

For detailed report with TOC, please click here ​Global Endometriosis Market 2016-2020.

Market Growth: The global endometriosis market is expected to grow at a CAGR of 2.05% during the period 2016-2020.

Key vendors 
• AbbVie
• AstraZeneca
• Bayer HealthCare
• Pfizer

Other prominent vendors 
• Addex Therapeutics 
• Astellas Pharma 
• Debiopharm
• ElexoPharm 
• Endoceutics 
• Euroscreen 
• Forendo Pharma 
• Isifer 
• Kissei Pharmaceutical 
• Neurocrine Biosciences
• Nippon Shinyaku 
• ObsEva
• Orphagen Pharmaceuticals 
• Philogen
• PregLem 
• Repros Therapeutics 
• Roivant Sciences
• SK Chemicals 
• Speciality European Pharma
• SYNG Pharmaceuticals
• Takeda
• United Pharmaceuticals 
• ValiPharma

Regions Covered: 

• Americas
• APAC
• EMEA

Companies Mentioned

AbbVie, AstraZeneca, Bayer HealthCare, Pfizer, Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, Endoceutics, Euroscreen, Forendo Pharma, Isifer, Kissei Pharmaceutical, Neurocrine Biosciences, Nippon Shinyaku, ObsEva, Orphagen Pharmaceuticals, Philogen, PregLem, Repros Therapeutics, Roivant Sciences, SK Chemicals, Speciality European Pharma, SYNG Pharmaceuticals, Takeda, United Pharmaceuticals, ValiPharma.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###